Search

Search Constraints

You searched for: Author/Creator Delpretti, Saskia

Search Results

1. ACI‐24 in adults with Down syndrome: Results of a phase 1b, randomized, placebo‐controlled study. (31st December 2021)

2. ACI‐24 in adults with Down syndrome: Results of a phase 1b, randomized, placebo‐controlled study. (31st December 2021)

3. ACI‐24 vaccine in adults with Down syndrome: Human: Putative therapeutic results for Alzheimer's and related dementias. (7th December 2020)

4. Biomarker‐based development for optimized ACI‐24, a novel candidate vaccine for the treatment and prevention of Alzheimer's disease. (20th December 2022)

5. Optimized ACI‐24, an amyloid beta (Abeta) vaccine that safely drives immunity to oligomers and Pyroglutamate Abeta, key pathological species of Alzheimer's disease (AD). (20th December 2022)